Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Sponsor: Oxford BioMedica
Summary
The purpose of this study is to examine the long term safety of an experimental gene transfer agent, RetinoStat®, designed to treat neovascular age-related macular degeneration.
Official title: A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2012-08
Completion Date
2029-03
Last Updated
2026-01-14
Healthy Volunteers
No
Conditions
Interventions
RetinoStat
Long Term Follow up of patients who received RetinoStat in a previous study
Locations (3)
University of Iowa Hospitals & Clinics
Iowa City, Iowa, United States
John Hopkins University Hospital
Baltimore, Maryland, United States
Oregon Health & Science University
Portland, Oregon, United States